Burcon Announces Chief Financial Officer Transition
Burcon NutraScience (OTCQB: BRCNF), a global technology leader in plant-based protein innovation, has announced the appointment of Ms. Alex Varty as Interim Chief Financial Officer, effective August 4, 2025. She succeeds Mr. Robert Peets, who served as CFO since July 2024.
Ms. Varty, who joined Burcon in February 2024, brings significant experience in finance and accounting, including senior roles at KPMG LLP. She is a Chartered Professional Accountant with a Bachelor of Science in Biotechnology/Chartered Professional Accounting from the University of Waterloo. The transition comes as Burcon continues its evolution into a revenue-generating, innovation company.
Burcon NutraScience (OTCQB: BRCNF), leader globale nella tecnologia e innovazione delle proteine vegetali, ha annunciato la nomina di Ms. Alex Varty come Chief Financial Officer ad interim, a partire dal 4 agosto 2025. Succede a Mr. Robert Peets, che ha ricoperto il ruolo di CFO da luglio 2024.
Ms. Varty, entrata in Burcon nel febbraio 2024, porta con sé una vasta esperienza in finanza e contabilità , avendo ricoperto posizioni di rilievo presso KPMG LLP. È una contabile professionista certificata con una laurea in Biotecnologie/Contabilità Professionale presso l'Università di Waterloo. Questa transizione avviene mentre Burcon continua la sua trasformazione in un'azienda innovativa e generatrice di ricavi.
Burcon NutraScience (OTCQB: BRCNF), lÃder global en innovación tecnológica de proteÃnas de origen vegetal, ha anunciado el nombramiento de Ms. Alex Varty como Directora Financiera interina, con efecto a partir del 4 de agosto de 2025. Ella sucede al Sr. Robert Peets, quien desempeñó el cargo de CFO desde julio de 2024.
Ms. Varty, que se unió a Burcon en febrero de 2024, aporta una amplia experiencia en finanzas y contabilidad, incluyendo cargos senior en KPMG LLP. Es Contadora Profesional Certificada y posee una Licenciatura en BiotecnologÃa/Contabilidad Profesional de la Universidad de Waterloo. La transición se produce mientras Burcon continúa su evolución hacia una empresa innovadora y generadora de ingresos.
Burcon NutraScience (OTCQB: BRCNF)ëŠ� ì‹ë¬¼ì„� 단백ì§� í˜ì‹ 분야ì� 글로벌 ê¸°ìˆ ì„ ë„ ê¸°ì—…ìœ¼ë¡œì„�, 2025ë…� 8ì›� 4ì�ë¶¶Äë¡� Alex Varty ì”�ë¥� 임시 ìµœê³ ìž¬ë¬´ì±…ìž„ìž�(CFO)ë¡� 임명했다ê³� 발표했습니다. 그녀ëŠ� 2024ë…� 7월부í„� CFOë¥� ì—ìž„í•� Robert Peets ì”¨ì˜ ë’¤ë¥¼ 잇습니다.
2024ë…� 2ì›� Burconì—� 합류í•� Varty 씨는 KPMG LLPì—서ì� ê³ ìœ„ì§� ê²½ë ¥ì� í¬í•¨í•� 재무 ë°� 회계 분야ì—서 í’ë¶€í•� 경험ì� ë³´ìœ í•˜ê³ ìžˆìŠµë‹ˆë‹¤. 그녀ëŠ� 워털ë£� 대학êµì—서 ìƒëª…공학 ë°� ê³µì¸íšŒê³„ì‚� 학사 학위ë¥� ì·¨ë“í•� ê³µì¸íšŒê³„사입니다. ì´ë²ˆ ì¸ì‚¬ëŠ� Burconì� ìˆ˜ìµ ì°½ì¶œ í˜ì‹ 기업으로 ê³„ì† ë°œì „í•˜ëŠ” ê°€ìš´ë° ì´ë£¨ì–´ì¡ŒìŠµë‹ˆë‹�.
Burcon NutraScience (OTCQB : BRCNF), leader mondial de la technologie dans l'innovation des protéines à base de plantes, a annoncé la nomination de Mme Alex Varty en tant que Directrice Financière par intérim, à compter du 4 août 2025. Elle succède à M. Robert Peets, qui occupait le poste de CFO depuis juillet 2024.
Mme Varty, qui a rejoint Burcon en février 2024, apporte une solide expérience en finance et comptabilité, ayant notamment occupé des postes à responsabilité chez KPMG LLP. Elle est comptable professionnelle agréée et détient un Bachelor of Science en biotechnologie/comptabilité professionnelle de l'Université de Waterloo. Cette transition intervient alors que Burcon poursuit son évolution en tant qu'entreprise innovante génératrice de revenus.
Burcon NutraScience (OTCQB: BRCNF), ein weltweit führendes Technologieunternehmen im Bereich pflanzlicher Proteininnovationen, hat die Ernennung von Frau Alex Varty zur interimistischen Chief Financial Officer bekannt gegeben, wirksam ab dem 4. August 2025. Sie tritt die Nachfolge von Herrn Robert Peets an, der seit Juli 2024 als CFO tätig war.
Frau Varty, die im Februar 2024 zu Burcon kam, bringt umfassende Erfahrung in den Bereichen Finanzen und Buchhaltung mit, unter anderem in leitenden Positionen bei KPMG LLP. Sie ist eine zertifizierte Wirtschaftsprüferin mit einem Bachelor of Science in Biotechnologie und Wirtschaftsprüfung von der University of Waterloo. Der Wechsel erfolgt, während Burcon sich weiterhin zu einem umsatzgenerierenden Innovationsunternehmen entwickelt.
- New CFO brings strong financial and biotechnology background
- Company successfully completed a rights offering fundraise in the past year
- Company is transitioning to revenue-generating status
- Interim CFO appointment indicates temporary leadership in key financial role
- Second CFO change in just over one year
Vancouver, British Columbia--(Newsfile Corp. - August 5, 2025) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in plant-based protein innovation, is pleased to announce that Ms. Alex Varty has been appointed Interim Chief Financial Officer ("CFO") of Burcon effective August 4, 2025. Ms. Varty succeeds Mr. Robert Peets, who has served as CFO on a fractional basis since July 1, 2024, and will continue to support the Company as a consultant. Burcon extends its sincere thanks to Mr. Peets for his contributions and wishes him continued success in his future endeavors.
Kip Underwood, Burcon’s chief executive officer, commented: “On behalf of the entire Burcon team and our board of directors, I would like to thank Robert for his executive leadership and contributions since joining our management team. In the past year, Robert played a crucial role in our successful rights offering fund raise. Alex has been instrumental in our transition to a revenue-generating, innovation company. Her experience and dedication will support us through this commercial phase.”
Ms. Varty joined the Company in February 2024 and has since taken on the Company's financial and accounting responsibilities. She brings years of experience in finance, accounting, and corporate governance, having previously held senior roles in public accounting at KPMG LLP and in industry. Ms. Varty is a Chartered Professional Accountant and holds a Bachelor of Science degree in Biotechnology / Chartered Professional Accounting from the University of Waterloo.
About Burcon NutraScience Corporation
Burcon is a global technology leader in high-performance plant-based proteins for the food and beverage industry. Our commercial ingredients offer superior taste, texture, and functionality-ideal for formulators seeking next-generation protein solutions. Backed by over two decades of innovation, Burcon holds an extensive patent portfolio covering novel proteins derived from pea, canola, soy, hemp, sunflower, and other plant sources. As a key player in the rapidly growing plant-based market, Burcon is committed to sustainability and to creating best-in-class protein solutions that are better for people and the planet. Learn more at .
Forward-Looking Information Cautionary Statement
The TSX has not reviewed and does not accept responsibility for the adequacy of the content of the information contained herein. This press release contains forward-looking statements or forward-looking information within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and applicable Canadian securities legislation. Forward-looking statements or forward-looking information involve risks, uncertainties and other factors that could cause actual results, performances, prospects and opportunities to differ materially from those expressed or implied by such forward-looking statements. Forward-looking statements or forward-looking information can be identified by words such as "anticipate," "aim", "intend," "plan," "goal," "project," "estimate," "expect," "believe," "future," "likely," "may," "should," "could," "will" and similar references to future periods. All statements included in this release, other than statements of historical fact, are forward-looking statements. There can be no assurance that such statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such statements or information. Important factors that could cause actual results to differ materially from Burcon's plans and expectations include the implementation of our business model and growth strategies; trends and competition in our industry our future business development, financial condition and results of operations and our ability to obtain financing cost-effectively; potential changes of government regulations, and other risks and factors detailed herein and from time to time in the filings made by Burcon with securities regulators and stock exchanges, including in the section entitled "Risk Factors" in Burcon's annual information form for the year ended March 31, 2025 and its other public filings with Canadian securities regulators on SEDAR+ at . This list is not exhaustive of the factors that may affect any of the Company's forward-looking statements or information. Any forward-looking statement or information speaks only as of the date on which it was made, and, except as may be required by applicable securities laws, Burcon disclaims any intent or obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise. Although Burcon believes the assumptions inherent in the forward-looking statements are reasonable, forward-looking statements are not guarantees of future performance, and, accordingly, investors should not rely on such statements.
Industry and Investor Contact
Paul Lam
Director, Investor Relations and Communications
Burcon NutraScience Corporation
490 - 999 West Broadway, Vancouver, BC, V5Z 1K5
Tel (604) 733-0896, Toll-free (888) 408-7960
[email protected]
Media Contact:
Steve Campbell, APR
President
Campbell & Company Public Relations
Tel (604) 888-5267
[email protected]
To view the source version of this press release, please visit